Literature DB >> 13803290

The actions of bretylium: adrenergic neurone blocking and other effects.

A L BOURA, A F GREEN.   

Abstract

Bretylium caused a specific and lasting depression of many excitatory and inhibitory responses evoked by electrical stimulation of the peripheral sympathetic nervous system, probably by impairing conduction of impulses in adrenergic neurones with consequent failure of noradrenaline and adrenaline release. This effect, which will be referred to as the adrenergic neurone blocking action, was preceded by weak sympathomimetic effects. In the presence of bretylium the effects of adrenaline and noradrenaline were increased, as after sympathectomy. Concentrations producing blocking of adrenergic neurones did not prevent the release of adrenaline and noradrenaline from the adrenal medulla by splanchnic nerve stimulation or by the injection of dimethylphenylpiperazinium iodide, nor did they cause antiparasympathetic or parasympathomimetic effects. No action on the central nervous system has been detected. Curare-like neuromuscular block occurred with 10 to 30 times the amount required to block the response to adrenergic nerve stimulation alone and was accompanied by signs of temporary synaptic block in autonomic ganglia. Adrenergic nerve trunks and sensory nerves in the skin were readily blocked for long periods by topical application of bretylium, whereas the phrenic nerve of the rat was not. Bretylium had little effect on gastrointestinal propulsion or on the sensitivity of smooth muscle to acetylcholine, 5-hydroxytryptamine, adrenaline, or noradrenaline, but moderate amounts depressed the peristaltic reflex and the sensitivity of the guinea-pig ileum to histamine. Bretylium caused postural hypotension in the cat in doses which had little effect on the supine blood pressure. Experiments on the nictitating membrane indicated that compensation for the effects of bretylium on low rates of stimulation of postganglionic sympathetic nerves could be attained by a small increase in the rate of stimulation, whereas compensation for its effects on high rates required an increase in the rate of stimulation beyond physiological limits.

Entities:  

Keywords:  SYMPATHOLYTICS/pharmacology

Mesh:

Substances:

Year:  1959        PMID: 13803290      PMCID: PMC1481902          DOI: 10.1111/j.1476-5381.1959.tb00961.x

Source DB:  PubMed          Journal:  Br J Pharmacol Chemother        ISSN: 0366-0826


  12 in total

1.  The actions of digitalis leaf preparations and of cardiac glycosides on the isolated right ventricle of the guinea pig.

Authors:  G A STEWART
Journal:  J Pharm Pharmacol       Date:  1958-12       Impact factor: 3.765

2.  The output of sympathetic transmitter from the spleen of the cat.

Authors:  G L BROWN; J S GILLESPIE
Journal:  J Physiol       Date:  1957-08-29       Impact factor: 5.182

3.  In-vitro formation of noradrenaline from dopamine by human tissue.

Authors:  W A BAIN; R FIELDEN
Journal:  Lancet       Date:  1957-09-07       Impact factor: 79.321

4.  Choline 2 : 6-xylyl ether bromide; an active quaternary local anaesthetic.

Authors:  P HEY; G L WILLEY
Journal:  Br J Pharmacol Chemother       Date:  1954-12

5.  Acetylcholine release in the cat's superior cervical ganglion.

Authors:  W L M PERRY
Journal:  J Physiol       Date:  1953-03       Impact factor: 5.182

6.  The estimation of adrenaline and allied substances in blood.

Authors:  J H Gaddum; W S Peart; M Vogt
Journal:  J Physiol       Date:  1949-06-15       Impact factor: 5.182

7.  The paralysis of autonomic ganglia, with special reference to the therapeutic effect of ganglion-blocking drugs.

Authors:  W D M PATON
Journal:  Br Med J       Date:  1951-04-14

8.  The antagonism of cocaine to the action of choline 2,6-xylyl ether bromide at sympathetic nerve endings.

Authors:  P A NASMYTH; W H ANDREWS
Journal:  Br J Pharmacol Chemother       Date:  1959-12

9.  Some actions of substituted choline phenyl ethers, particularly of choline 2:6-xylyl ether.

Authors:  N D EDGE; D F MASON; J H WYLLIE
Journal:  Br J Pharmacol Chemother       Date:  1957-09

10.  The blocking action of choline 2:6-xylyl ether bromide on adrenergic nerves.

Authors:  K A EXLEY
Journal:  Br J Pharmacol Chemother       Date:  1957-09
View more
  89 in total

1.  Some physiological and pharmalogical characteristics of the stimulus induced release of norepinephrine from the rabbit superior cervical ganglion.

Authors:  J P Noon; R H Roth
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1975       Impact factor: 3.000

2.  Atrial receptors and heart rate: the efferent pathway.

Authors:  C T Kappagoda; R J Linden; E M Scott; H M Snow
Journal:  J Physiol       Date:  1975-08       Impact factor: 5.182

3.  History of research into hypertension.

Authors:  A L Boura
Journal:  J R Soc Med       Date:  1992-08       Impact factor: 5.344

4.  MODIFICATION OF THE EFFECTS OF GUANETHIDINE ON CARDIAC CATECHOL AMINES BY VARIOUS AGENTS.

Authors:  B BHAGAT
Journal:  Br J Pharmacol Chemother       Date:  1964-04

5.  A REFLEX INCREASE IN HEART RATE FROM DISTENSION OF THE PULMONARY-VEIN-ATRIAL JUNCTIONS.

Authors:  J R LEDSOME; R J LINDEN
Journal:  J Physiol       Date:  1964-04       Impact factor: 5.182

6.  THE EFFECT OF BRETYLIUM TOSYLATE ON SOME CARDIOVASCULAR REFLEXES.

Authors:  J R LEDSOME; R J LINDEN
Journal:  J Physiol       Date:  1964-04       Impact factor: 5.182

7.  Adrenergic neurone blockade and other acute effects caused by N-benzyl-N'N"-dimethylguanidine and its ortho-chloro derivative.

Authors:  A L BOURA; A F GREEN
Journal:  Br J Pharmacol Chemother       Date:  1963-02

8.  The effect of eserine on the response of the vas deferens to hypogastric nerve stimulation.

Authors:  J H BURN; D F WEETMAN
Journal:  Br J Pharmacol Chemother       Date:  1963-02

9.  Effect of noradrenaline on the action of nicotine and tyramine on isolated atria.

Authors:  D L AZARNOFF; J H BURN
Journal:  Br J Pharmacol Chemother       Date:  1961-06

10.  THE ISOLATED PILOMOTOR MUSCLES AS AN IN VITRO PREPARATION.

Authors:  K HELLMANN
Journal:  J Physiol       Date:  1963-12       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.